Affiliations 

  • 1 Centre for Natural Product Research and Drug Discovery (CENAR), Department of Chemistry, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia
  • 2 Institut de Chimie des Substances Naturelles, CNRS-ICSN UPR2301, Univ. Paris-Sud 11, av. de la Terrasse, 91198 Gif-sur-Yvette, France
  • 3 Institut de Chimie des Substances Naturelles, CNRS-ICSN UPR2301, Univ. Paris-Sud 11, av. de la Terrasse, 91198 Gif-sur-Yvette, France. Electronic address: marc.litaudon@cnrs.fr
  • 4 Centre for Natural Product Research and Drug Discovery (CENAR), Department of Chemistry, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia. Electronic address: khalijah@um.edu.my
Fitoterapia, 2016 Mar;109:190-5.
PMID: 26779944 DOI: 10.1016/j.fitote.2016.01.004

Abstract

A phytochemical study of the EtOAc-soluble part of the methanolic extract of the bark of Endiandra kingiana led to the isolation of three new pentacyclic kingianins as racemic mixtures, kingianins O-Q (1-3), together with the known kingianins A, F, K, L, M and N (4-9), respectively. The structures of the new kingianins 1-3 were determined by 1D and 2D NMR analysis in combination with HRESIMS experiments. Kingianins A-Q were assayed for Mcl-1 binding affinity. Kingianins G and H were found to be potent inhibitors of Mcl-1/Bid interaction. A structure-activity relationship study showed that potency is very sensitive to the substitution pattern on the pentacyclic core. In addition, in contrast with the binding affinity for Bcl-xL, the levorotatory enantiomers of kingianins G, H and J exhibited similar binding affinities for Mcl-1 than their dextrorotatory counterparts, indicating that the two anti-apoptotic proteins have slightly different binding profiles.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.